Company: EDSA
Filing Date: 2025-09-09
Form Type: 8-K
Source: 0001171843-25-005800
Chunk: 1

Company: Edesa Biotech, Inc.
Filing Date: 2025-09-09
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are furnished
with this Current Report on Form 8-K:

  Exhibit      Exhibit Description                                                                                          
   Number                                                                                                                   
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      5.1      Opinion of Fasken Martineau DuMoulin LLP                                                                     
     23.1      Consent of Fasken Martineau DuMoulin LLP (included in Exhibit 5.1)                                           
      104      Cover Page Interactive Data File (the cover page XBRL tags are embedded within in the inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               Edesa Biotech, Inc.                               
  Date: September 9, 2025      By:                      /s/ Peter Weiler         
                               Name:                    Peter Weiler             
                               Title:                   Chief Financial Officer